Showing items 101–112
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
Application WO-2017182881-A3
World Intellectual Property Organisation (WIPO)
Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction
Grant US-9822355-B2
United States of America
Engineered CRISPR-CAS9 nucleases with altered PAM specificity
Grant US-9752132-B2
United States of America
METHODS FOR MODULATING DNA REPAIR OUTCOMES
Application WO-2017147056-A1
World Intellectual Property Organisation (WIPO)
COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
Application WO-2017115268-A1
World Intellectual Property Organisation (WIPO)
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
Application WO-2017114497-A1
World Intellectual Property Organisation (WIPO)
METHODS FOR IDENTIFYING AND TREATING HEMOGLOBINOPATHIES
Application WO-2017117331-A1
World Intellectual Property Organisation (WIPO)
NOVEL CRISPR ENZYMES AND SYSTEMS
Application WO-2016205764-A1
World Intellectual Property Organisation (WIPO)
FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS FOR SATURATING MUTAGENESIS OF NON-CODING…
Application WO-2016182893-A1
World Intellectual Property Organisation (WIPO)
TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION
Application EP-2925864-A4
European Patent Office
CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
Application WO-2016106244-A1
World Intellectual Property Organisation (WIPO)
Showing items 101–112